NASDAQ:NVCR
NovoCure Limited Stock News
$16.47
+0.340 (+2.11%)
At Close: May 10, 2024
NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2019 Results - Earnings Call Transcript
07:14pm, Thursday, 27'th Feb 2020
NovoCure Limited (NASDAQ:NVCR) Q4 2019 Earnings Conference Call February 27, 2020 8:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Fina
Healthcare Faces A Contagion
02:36pm, Thursday, 27'th Feb 2020
Fear mounts as investors brace for a viral outbreak in the US. Volatility to remain high as Covid-19 virus remains an unknown threat. Impact on earnings outlook
NovoCure (NVCR) Q4 Earnings and Revenues Beat Estimates
12:30pm, Thursday, 27'th Feb 2020
NovoCure (NVCR) delivered earnings and revenue surprises of 300.00% and 0.11%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) Q4 Earnings and Revenues Beat Estimates
12:30pm, Thursday, 27'th Feb 2020
NovoCure (NVCR) delivered earnings and revenue surprises of 300.00% and 0.11%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
11:00am, Thursday, 27'th Feb 2020
ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure today reported fourth quarter and full year 2019 financial results and provided a company update.
NovoCure (NVCR) Earnings Expected to Grow: Should You Buy?
05:31pm, Thursday, 20'th Feb 2020
NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NovoCure (NVCR) Earnings Expected to Grow: Should You Buy?
05:31pm, Thursday, 20'th Feb 2020
NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
